CCND2 and neoplasm: CCND2 is overexpressed in gastric, ovarian, and testicular cancer20, 27, 28 and its overexpression in NSCLC tumor formation is not completely understood despite a report showing that miR‐4317 suppresses NSCLC growth through inhibition of CCND2.29